Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
Accelerating battery research with robots
Sustainable lithium from geothermal power plants
Rechargeable batteries of the future?
Lithuanian invention at the forefront of solar technology breakthrough
Carnot batteries as energy storage of the future
ReCatalyst closes oversubscribed seed financing round